Crossmark

A Real-World Target Trial Emulation of Eteplirsen, Casimersen, and Golodirsen to Evaluate Survival Among Patients with Duchenne Muscular Dystrophy

Published Online: 2026-06-06

Authors

Dharmarajan, Sai

Grabich, Shannon https://orcid.org/0000-0003-3474-6874
Baxter, Richard https://orcid.org/0009-0008-0712-1135
Nadkar, Aalok

Schermer, Carol
Funding

Funding for this research was provided by:

Sarepta Therapeutics
License Information

Text and Data Mining valid from 2026-06-06

Version of Record valid from 2026-06-06
More Information

Article History

Received: 8 December 2025

Accepted: 10 April 2026

First Online: 6 June 2026

Document is current